Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080033 | SCV000111927 | benign | not specified | 2013-08-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080033 | SCV000309191 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001511826 | SCV001719134 | benign | Sphingolipid activator protein 1 deficiency | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001538043 | SCV001755048 | benign | Combined PSAP deficiency | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001538044 | SCV001755049 | benign | Krabbe disease due to saposin A deficiency | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001511826 | SCV001755050 | benign | Sphingolipid activator protein 1 deficiency | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676143 | SCV001909811 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676143 | SCV005321847 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676143 | SCV000801889 | benign | not provided | 2015-10-22 | no assertion criteria provided | clinical testing |